Lv3
266 积分 2024-07-30 加入
KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)
4天前
已完结
Pioglitazone Improves Mitochondrial Function in the Remnant Kidney and Protects against Renal Fibrosis in 5/6 Nephrectomized Rats
27天前
已完结
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation
29天前
已完结
Efficacy and safety of Nefecon in IgA nephropathy: real world clinical practice
29天前
已完结
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
1个月前
已完结
Efficacy and Safety of Nefecon in Patients with Immunoglobulin A Nephropathy from Mainland China: 2-Year NefIgArd Trial Results
1个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
1个月前
已完结
Asiaticoside attenuates renal fibrosis by targeting STAT3 to restore Th17/Treg homeostasis
1个月前
已完结
HPDA-based tubule-targeting nanoplatform alleviates oxidative stress and ferroptosis for the reversal of renal interstitial fibrosis
2个月前
已关闭
Mechanisms of norcantharidin against renal tubulointerstitial fibrosis
2个月前
已完结
皖公网安备34019202002308
